# MYTHS - MYocarditis THerapy With Steroids

Study · id `cardio:ct-nct05150704` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05150704](<https://clinicaltrials.gov/study/NCT05150704>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT05150704

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 288 participants.

## Technical summary

Registry record NCT05150704. Randomized; single masking; primary purpose treatment. Start 2021-10-07 (actual); primary completion 2028-03 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 288 participants (planned count; ClinicalTrials.gov record NCT05150704, source copy `cardio:ctgov-nct05150704-2025-07-31`, retrieved 2026-10-31)
- Started: 2021-10-07 (actual) (ClinicalTrials.gov record NCT05150704, source copy `cardio:ctgov-nct05150704-2025-07-31`, retrieved 2026-10-31)
- Primary completion: 2028-03 (anticipated) (ClinicalTrials.gov record NCT05150704, source copy `cardio:ctgov-nct05150704-2025-07-31`, retrieved 2026-10-31)
- Completion: 2028-12 (anticipated) (ClinicalTrials.gov record NCT05150704, source copy `cardio:ctgov-nct05150704-2025-07-31`, retrieved 2026-10-31)
- Countries: United States; Austria; Belgium; Czechia; Finland; Italy; Slovenia; Spain; Sweden (ClinicalTrials.gov record NCT05150704, source copy `cardio:ctgov-nct05150704-2025-07-31`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05150704-2025-07-31`, retrieved 2026-10-31)

## The registry's words

- Brief title: MYTHS - MYocarditis THerapy With Steroids
- Acronym: MYTHS
- Condition: Myocarditis Acute
- Intervention (Drug): Methylprednisolone
- Intervention (Drug): saline solution
- Lead sponsor: Niguarda Hospital
- Lead sponsor class: OTHER
- Collaborator: Ministry of Health, Italy
- Collaborator class: OTHER\_GOV
- Collaborator: Istituto Di Ricerche Farmacologiche Mario Negri
- Collaborator class: OTHER
- Collaborator: University of Milano Bicocca
- Collaborator class: OTHER
- Collaborator: Regione Lombardia
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Cardiomyopathy (heart muscle disease) (`cardio:cardiomyopathy`)
- Registry lists this organization as a collaborator: Ministry of Health, Italy (`cardio:org-ministry-of-health-italy`)

## Provenance

Content hash: 2c7ad403eb6da3810f0ac07732ece1eb6712ad02fe3ba978267da0185e04d50d
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
